Ignite Creation Date:
2024-05-06 @ 5:56 PM
Last Modification Date:
2024-10-26 @ 2:38 PM
Study NCT ID:
NCT05489887
Status:
RECRUITING
Last Update Posted:
2024-04-08
First Post:
2022-08-04
Brief Title:
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Sponsor:
Giselle Sholler
Organization:
Milton S Hershey Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-09
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-04
First Submit QC Date:
August 4 2022
Study First Post Date:
2022-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-24
Last Update Post Date:
2024-04-08
Last Update Post Date Type:
ACTUAL